- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
A Study of Persistence of Anti-HBs Antibodies after Vaccination with Recombinant Hepatitis B Vaccine in Healthcare Workers
-
- IWASAKI Sumio
- Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital Infection Control Center, Hokkaido University Hospital
-
- OYAMADA Reiko
- Infection Control Center, Hokkaido University Hospital
-
- WATANABE Tsubasa
- Infection Control Center, Hokkaido University Hospital
-
- HASUIKE Kiyomi
- Division of Hospital Safety Management, Hokkaido University Hospital
-
- NAKAMURA Sumito
- Infection Control Center, Hokkaido University Hospital
-
- YAMADA Takehiro
- Infection Control Center, Hokkaido University Hospital Division of Pharmacy, Hokkaido University Hospital
-
- OBA Koji
- Department of Biostatistics, School of Public Health, Graduate School of Medicine, The University of Tokyo
-
- ISHIGURO Nobuhisa
- Infection Control Center, Hokkaido University Hospital
Bibliographic Information
- Other Title
-
- 医療従事者における組換え沈降B型肝炎ワクチン接種後のHBs抗体持続期間に関する検討
Search this article
Description
<p>A total of 237 healthcare workers who had successfully acquired protective levels of anti-HBs antibodies (≥10 mIU/mL) by recombinant hepatitis B vaccine were followed up for a period of five years. Only 2.0% of the vaccinees who had acquired anti-HBs antibody levels of 10-49 mIU/mL four months after the third dose of vaccine had anti-HBs antibody levels higher than 10 mIU/mL five years later, and only 16.7% of the vaccinees who had acquired anti-HBs antibody levels of 50-99 mIU/mL four months after the third dose of vaccine had anti-HBs antibody levels higher than 10 mIU/mL five years later. On the other hand, 87.0% of the vaccinees who had acquired anti-HBs antibody levels of ≥400 mIU/mL four months after the third dose of vaccine had anti-HBs antibody levels higher than 10 mIU/mL five years later. Persistence of anti-HBs antibodies depends on the anti-HBs titer at four months after the third dose of recombinant hepatitis B vaccine.</p>
Journal
-
- Japanese Journal of Infection Prevention and Control
-
Japanese Journal of Infection Prevention and Control 33 (3), 117-122, 2018-05-25
Japanese Society for Infection Prevention and Control
- Tweet
Details 詳細情報について
-
- CRID
- 1390282763071872384
-
- NII Article ID
- 130007521472
-
- ISSN
- 18832407
- 1882532X
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed